New hope for tough prostate cancer: drug cocktail trial underway
NCT ID NCT02703623
First seen Nov 10, 2025 · Last updated May 20, 2026 · Updated 27 times
Summary
This study tests different combinations of approved drugs to treat men with advanced prostate cancer that has spread and no longer responds to hormone therapy. About 196 men will receive either a standard hormone-blocking combo or that combo plus an immunotherapy or chemotherapy drug. The goal is to see which mix works best to control the cancer and improve survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATION-RESISTANT PROSTATE CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
MD Anderson in Katy
Houston, Texas, 77094, United States
-
MD Anderson in Sugar Land
Sugar Land, Texas, 77478, United States
Conditions
Explore the condition pages connected to this study.